When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ImmunoGen (IMGN) is a late clinical stage pharmaceutical company with a potential cancer therapy. It was once a relatively high-flyer, with a stock price about 5 times today's, back in July of 2013. That was based largely on early trial data from the drug Mirvetuximab soravtansine, or mirv. This article will look at the possibility of a mirv comeback, and weigh that against the current stock price and market capitalization.